Radiopharmaceuticals Market Growth in Future- Comprehensive Study on Key Players: Cardinal Health, MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging, Bayer AG, Bracco Imaging SpA, Nordion, IBA Molecular Imaging, CovidienPlc, Positron Corporation,
Radiopharmaceuticals market report is a comprehensive study on how the Information and Communication Technology industry is changing because of radiopharmaceuticals market.
"Global Radiopharmaceuticals Market" is predictable to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Download PDF Sample Copy of Report Visit @
Top countries covered in this report are
U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others
• Cardinal Health Inc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• Actinium Pharmaceuticals Inc.,
• Among others.
Radiopharmaceuticals market analysis
The Radiopharmaceuticals Market analysis report covers detailed value chain analysis of the Market. The value chain analysis helps to analyze major upstream raw materials, major equipment’s, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restrain for the market.
Major Points from Table of Content:
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
Request for Table of Content of Full Report @ https://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.
It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of where areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.
Radiopharmaceuticals Market report give rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent.
Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities.
Recent trends in the radiopharmaceuticals market such as growing disease which targeted cancer therapy, increasing awareness, expanding applications of molecular imaging, technological advancement, increasing trend of radio-labelled peptides and monoclonal antibodies for the diagnosis and treatment of cancer tumors and increasing use of SPECT & PET scans is expected to drive the market in the forecast period 2017 to 2024.
Radiopharmaceuticals are mostly used for treatment of cancer, bone pain, and thyroid cancer. In the U.S. cancer is second fatal disease whereas in the UK it is the leading cause of death. In most of the third world countries cancer appears much lower. Cancer is the second leading cause of death globally and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to cancer. In 2016, an estimated 1.6 million new cases of cancer was diagnosed in the United States and 0.5 million people died from the disease.
• Ambulatory surgical centers,
• diagnostic centers,
• Cancer research institutes and
Any Specific Requirements? Questions? Ask to Our Industry Expert @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market
On the basis of type,
• Therapeutic radiopharmaceuticals.
On the basis of procedural volumes,
1. Diagnostic procedure
• single-photon emission computed tomography (SPECT) radiopharmaceuticals
• positron emission tomography (PET) radiopharmaceuticals
2. Therapeutic procedures
• beta emitters
• alpha emitters
• brachy therapy
On the basis of application,
1. diagnostic application
• single-photon emission computed tomography (SPECT) -
• positron emission tomography (PET)- oncology, cardiology, neurology and others
2. therapeutic application
• bone metastasis,
• endocrine tumours
On the basis of sources,
• nuclear reactors
based on geography
• North America,
• South America
• Middle East and Africa
Key reason to Purchase the report
1. To describe and forecast the radiopharmaceuticals market, in terms of value, by process, product type, and industry.
2. To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders
3. To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)
4. To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the radiopharmaceuticals market growth
5. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various trocars across geographies.
6. To strategically analyze micro markets with respect to individual growth trends, prospects, and contribution to the overall market
Questions? Ask to Our Experts about the Market Report Visit @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiopharmaceuticals-market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market Growth in Future- Comprehensive Study on Key Players: Cardinal Health, MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging, Bayer AG, Bracco Imaging SpA, Nordion, IBA Molecular Imaging, CovidienPlc, Positron Corporation, here
News-ID: 1355428 • Views: 247
More Releases from Data Bridge Market Research
Electric Vehicle Market Emerging Trends and Competitive Outlook: Tesla, BYD, BMW …
Emerging trends, which have a direct impact on the dynamics of the market, include development of wireless charging infrastructure and introduction of multiple long-range EVs with low cost. A new market intelligence research report released by Data Bridge Market research with title Electric Vehicle Market (covering USA, Europe, China, Japan, India, South East Asia etc.) that provide information, statistics, facts and figures, corporate intelligence, economic data, innovation drivers which are
Endoscope Reprocessing Market: Global Scope and Price Analysis 2019-2026 || Top …
Global Endoscope Reprocessing Market is expected to rise from its initial estimated value of USD 1.57 billion in 2018 to an estimated value of USD 2.97 billion by 2026, registering a CAGR of 8.25% in the forecast period of 2019-2026. Get sample copy of the report: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-endoscope-reprocessing-market Top Competitors Mentioned in the Endoscope Reprocessing Market Research Report: Advanced Sterilization Products Division Ethicon US LLC., Cantel Medical, Laboratoires Anios, Olympus Corporation, HOYA Corporation,
Encephalitis Treatment Market to Set Phenomenal Growth| Heritage Pharma, Zydus C …
Global Encephalitis Treatment Market Research Report: By Type (Primary Encephalitis, Secondary Encephalitis), Treatment Type (Antiviral Agents, Steroid Injection, Immunoglobulin Therapy, Plasmapheresis, Others), Route of Administration (Oral, Parenteral) By End Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland,
Skid steer Loaders Market Emerging Trends & Competitive Outlook: Bobcat Company. …
Data Bridge Market Research has recently added a concise research on the "Global Skid steer Loaders Market" to depict valuable insights related to significant market trends driving the industry with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy to understand detailed analysis. The Global Skid steer Loaders Market report is a professional asset which offers the in depth analysis of the market and covers
More Releases for Radiopharmaceuticals
Global Radiopharmaceuticals Market Outlook 2020 Report
“Global Radiopharmaceuticals Market Outlook 2020” Report Highlight: * Global Radiopharmaceutical Market Overview * Global Radiopharmaceuticals Market Dynamics * FDA & EMA Guidelines for Radiopharmaceuticals * Global Radiopharmaceuticals Clinical Pipeline Insight by Company, Indication & Phase * Global Radiopharmaceuticals Clinical Pipeline: 133 Radiopharmaceuticals * Majority Radiopharmaceuticals in Preclinical Phase: 44 Radiopharmaceuticals * Marketed Radiopharmaceuticals: 19 Radiopharmaceuticals Download Report Sample Weblink: https://www.kuickresearch.com/report-Global-Radiopharmaceuticals-Market-Outlook-2020.php For Report Sample Contact: email@example.com Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario
Radiopharmaceuticals Market Estimated to Flourish by 2026
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached an estimated US$ 4,800 million value, and are
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a